Lv15
60 积分 2025-04-28 加入
Cadonilimab is effective and safe in recurrent cervical cancer
3天前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
3天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
3天前
已完结
Improving survival from metastatic, recurrent, or persistent cervical cancer
3天前
已完结
皖公网安备34019202002308
